| Literature DB >> 29605457 |
Victoria Monge-Fuentes1, Claudia Arenas2, Priscilla Galante2, Jacqueline Coimbra Gonçalves2, Márcia Renata Mortari2, Elisabeth Ferroni Schwartz2.
Abstract
The complex process of pain control commonly involves the use of systemic analgesics; however, in many cases, a more potent and effective polypharmacological approach is needed to promote clinically significant improvement. Additionally, considering side effects caused by current painkillers, drug discovery is once more turning to nature as a source of more efficient therapeutic alternatives. In this context, arthropod venoms contain a vast array of bioactive substances that have evolved to selectively bind to specific pharmacological targets involved in the pain signaling pathway, playing an important role as pain activators or modulators, the latter serving as promising analgesic agents. The current review explores how the pain pathway works and surveys neuroactive compounds obtained from arthropods' toxins, which function as pain modulators through their interaction with specific ion channels and membrane receptors, emerging as promising candidates for drug design and development.Entities:
Keywords: Acid-sensing ion channels; Glutamate; Purinergic receptors; Sodium channels; TRPV receptors; Voltage-dependent calcium channels
Mesh:
Substances:
Year: 2018 PMID: 29605457 DOI: 10.1016/j.pharmthera.2018.03.007
Source DB: PubMed Journal: Pharmacol Ther ISSN: 0163-7258 Impact factor: 12.310